Tandem Diabetes Care, Inc.
Simbols: TNDM
NASDAQ
35.24
USDTirgus cena šodien
-10.3481
P/E koeficients
-0.1231
PEG koeficients
2.28B
MRK Cap
- 0.00%
DIV ienesīgums
Tandem Diabetes Care, Inc. (TNDM) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1992.9 | 467.9 | 616.9 | 623.8 | |||||||||||||
balance-sheet.row.short-term-investments | 1595.91 | 409 | 444.4 | 552.6 | |||||||||||||
balance-sheet.row.net-receivables | 395.98 | 105.6 | 114.7 | 110.7 | |||||||||||||
balance-sheet.row.inventory | 580.59 | 157.9 | 111.1 | 68.6 | |||||||||||||
balance-sheet.row.other-current-assets | 58.89 | 16.6 | 7.2 | 8.4 | |||||||||||||
balance-sheet.row.total-current-assets | 3028.36 | 748 | 850 | 811.5 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 673.65 | 164.3 | 179.2 | 77.9 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 2.78 | 2.8 | 4.6 | 6.6 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2.78 | 2.8 | 4.6 | 6.6 | |||||||||||||
balance-sheet.row.long-term-investments | 20.2 | 10.1 | 8.3 | 0 | |||||||||||||
balance-sheet.row.tax-assets | -10.1 | -10.1 | -8.3 | 0 | |||||||||||||
balance-sheet.row.other-non-current-assets | 78.5 | 37.6 | 19 | 9.1 | |||||||||||||
balance-sheet.row.total-non-current-assets | 765.03 | 204.7 | 202.8 | 93.6 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 3793.39 | 952.7 | 1052.8 | 905.1 | |||||||||||||
balance-sheet.row.account-payables | 208.04 | 49.6 | 55.7 | 28 | |||||||||||||
balance-sheet.row.short-term-debt | 68.28 | 17.1 | 13.1 | 9.3 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 1606.27 | 398.6 | 406.8 | 305.4 | |||||||||||||
Deferred Revenue Non Current | 58.61 | 13.3 | 16.9 | 16.9 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 332.09 | 84.6 | 77.6 | 84.4 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 1769.59 | 443.8 | 447.5 | 340.2 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 537.13 | 130.6 | 136.6 | 33.2 | |||||||||||||
balance-sheet.row.total-liab | 2497.77 | 639 | 612.8 | 472 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 0.26 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | -3615.5 | -951.8 | -729.2 | -634.6 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -2.12 | 1.4 | -1.8 | -0.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4912.98 | 1264 | 1170.9 | 1068.3 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 1295.62 | 313.6 | 439.9 | 433.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3793.39 | 952.7 | 1052.8 | 905.1 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-equity | 1295.62 | 313.6 | 439.9 | 433.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3793.39 | - | - | - | |||||||||||||
Total Investments | 1595.91 | 409 | 444.4 | 552.6 | |||||||||||||
balance-sheet.row.total-debt | 1674.56 | 415.7 | 419.9 | 314.7 | |||||||||||||
balance-sheet.row.net-debt | 1277.57 | 356.8 | 247.4 | 243.5 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -222.61 | -222.6 | -94.6 | 15.6 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 15.71 | 15.7 | 14.3 | 13.8 | |||||||||||||
cash-flows.row.deferred-income-tax | 0 | 9.1 | 0 | 4.6 | |||||||||||||
cash-flows.row.stock-based-compensation | 88.08 | 88.1 | 84.9 | 60.8 | |||||||||||||
cash-flows.row.change-in-working-capital | -17.68 | -17.7 | -4.6 | 14.4 | |||||||||||||
cash-flows.row.account-receivables | 4.28 | 4.3 | -7.8 | -31 | |||||||||||||
cash-flows.row.inventory | -46.05 | -46.1 | -42.5 | -5 | |||||||||||||
cash-flows.row.account-payables | -4.86 | -4.9 | 24.5 | 10.3 | |||||||||||||
cash-flows.row.other-working-capital | 28.95 | 29 | 21.1 | 40 | |||||||||||||
cash-flows.row.other-non-cash-items | 104.69 | 95.6 | 50.5 | 2.3 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -31.81 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -51.6 | -51.6 | -43 | -23.5 | |||||||||||||
cash-flows.row.acquisitions-net | -69.5 | -69.5 | -25.7 | 9.3 | |||||||||||||
cash-flows.row.purchases-of-investments | -510.86 | -510.9 | -467.7 | -733.4 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 546.22 | 546.2 | 569.5 | 570 | |||||||||||||
cash-flows.row.other-investing-activites | 65.07 | 0 | 0 | -9.3 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -85.74 | -85.7 | 33.2 | -186.9 | |||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.common-stock-issued | 6.29 | 4.2 | 17.5 | 51.3 | |||||||||||||
cash-flows.row.common-stock-repurchased | -0.54 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.other-financing-activites | 2.31 | -0.1 | -0.6 | 0.6 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 4.11 | 4.1 | 16.9 | 51.9 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.21 | -0.2 | 0.8 | 0.2 | |||||||||||||
cash-flows.row.net-change-in-cash | -113.65 | -113.6 | 101.3 | -23.4 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 396.99 | 58.9 | 172.5 | 71.2 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 510.64 | 172.5 | 71.2 | 94.6 | |||||||||||||
cash-flows.row.operating-cash-flow | -31.81 | -31.8 | 50.5 | 111.4 | |||||||||||||
cash-flows.row.capital-expenditure | -51.6 | -51.6 | -43 | -23.5 | |||||||||||||
cash-flows.row.free-cash-flow | -83.41 | -83.4 | 7.5 | 87.8 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 747.72 | 747.7 | 801.2 | 702.8 | |||||||||||||
income-statement-row.row.cost-of-revenue | 380.03 | 380 | 388.2 | 326.6 | |||||||||||||
income-statement-row.row.gross-profit | 367.69 | 367.7 | 413 | 376.2 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 169.67 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 83.8 | 78.8 | 0 | 0 | |||||||||||||
income-statement-row.row.operating-expenses | 522.17 | 522.2 | 474.8 | 353.6 | |||||||||||||
income-statement-row.row.cost-and-expenses | 902.2 | 902.2 | 863 | 680.1 | |||||||||||||
income-statement-row.row.interest-income | 22.86 | 22.9 | 6.1 | 0.7 | |||||||||||||
income-statement-row.row.interest-expense | -3.67 | 7.6 | 4.3 | 4.3 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 12.98 | -78.8 | -31 | 7.1 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 83.8 | 78.8 | 0 | 0 | |||||||||||||
income-statement-row.row.total-operating-expenses | 12.98 | -78.8 | -31 | 7.1 | |||||||||||||
income-statement-row.row.interest-expense | -3.67 | 7.6 | 4.3 | 4.3 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 88.47 | 15.7 | 31 | 13.8 | |||||||||||||
income-statement-row.row.ebitda-caps | -56.7 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | -151.88 | -233.2 | -61.8 | 8.8 | |||||||||||||
income-statement-row.row.income-before-tax | -220.25 | -220.3 | -92.9 | 15.9 | |||||||||||||
income-statement-row.row.income-tax-expense | 2.36 | 2.4 | 1.7 | 0.3 | |||||||||||||
income-statement-row.row.net-income | -222.61 | -222.6 | -94.6 | 15.6 |
Biežāk uzdotie jautājumi
Kas ir Tandem Diabetes Care, Inc. (TNDM) kopējie aktīvi?
Tandem Diabetes Care, Inc. (TNDM) kopējie aktīvi ir 952658000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir 382418000.000.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.492.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir -1.276.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir -0.298.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir -0.203.
Kāda ir Tandem Diabetes Care, Inc. (TNDM) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir -222611000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 415667000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 522170000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 58868000.000.